Investor Jorey Chernett holds 19.6% of Kazia ADS
KAZIA THERAPEUTICS LTD (KZIA) received an amended Schedule 13G/A indicating that investor Jorey Chernett beneficially owns a significant stake in the company’s American Depositary Shares (ADS).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KAZIA THERAPEUTICS LTD (KZIA) received an amended Schedule 13G/A indicating that investor Jorey Chernett beneficially owns a significant stake in the company’s American Depositary Shares (ADS).
As of the close of business on August 19, 2026, Chernett beneficially owned 2,339,009 ADS, representing 19.6% of the ADS class, based on 11,926,899 ADS outstanding as of the same date. Chernett reports sole voting and sole dispositive power over all 2,339,009 ADS, with no shared voting or dispositive power.
Key Figures
Key Terms
beneficially owned financial
CUSIP No. financial
Sole Voting Power financial
Sole Dispositive Power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of KZIA does Jorey Chernett report owning in this Schedule 13G/A?
What is the total number of KZIA ADS outstanding used in this ownership calculation?
What dispositive power does Jorey Chernett report over his KZIA holdings?
What security class of KZIA is covered in this Schedule 13G/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.